Location History:
- Lugwigshafen, DE (2015)
- Mannheim, DE (2014 - 2017)
- Wiesbaden, DE (2015 - 2017)
- Ludwigshafen, DE (2012 - 2018)
Company Filing History:
19 out of 150 
14 out of 822 
3 out of 139 
Years Active: 2012-2018
Title: Katja Jantos: Innovator in Pharmaceutical Chemistry
Introduction: Katja Jantos, residing in Ludwigshafen, Germany, is a prolific inventor with a remarkable portfolio of 23 patents. Her contributions primarily focus on developing therapeutic compounds for treating various neurological and psychiatric disorders, showcasing her dedication to advancing medical science through innovative solutions.
Latest Patents: Among her latest groundbreaking patents is the invention of inhibitor compounds of phosphodiesterase type 10A. This invention involves novel carboxamide compounds along with pharmaceutical compositions containing them. These compounds offer invaluable therapeutic properties, particularly in treating and controlling medical disorders, specifically targeting neurological and psychiatric disorders to alleviate associated symptoms and reduce risk factors. Another notable patent from her portfolio includes oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent. This invention details substituted oxindole derivatives and their pharmaceutical compositions for the treatment of vasopressin-related diseases, further highlighting her innovative approach to addressing complex health challenges.
Career Highlights: Katja has made significant strides in her career while working for leading pharmaceutical companies, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her roles in these organizations have enabled her to leverage her research capabilities, contributing to the development of essential therapeutic solutions.
Collaborations: Throughout her career, Katja has collaborated with notable professionals such as Andreas Kling and Wilfried Hornberger. These collaborations have fostered an enriching environment for research and innovation, allowing for the advancement of new therapeutic strategies.
Conclusion: Katja Jantos stands out as an exceptional inventor in the pharmaceutical sector, with her extensive patent portfolio reflecting her commitment to improving health outcomes through innovative inventions. Her work continues to inspire the next generation of researchers and inventors in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.